Psilocybin as Psilocin (Qualitative), Serum/Plasma Test (4029SP)
||Psilocybin as Psilocin (Qualitative), Serum/Plasma
||Drug of Abuse Monitoring; This test is New York State approved.
||High Performance Liquid Chromatography/
TandemMass Spectrometry (LC-MS/MS)
||2 mL Serum or Plasma
||Plastic container (preservative-free)
||Serum: Collect sample in Red top tube
Plasma: Collect sample in Lavender top tube (EDTA) or Pink top tube.
Promptly centrifuge and separate Serum or Plasma into a plastic screw capped vial using approved guidelines.
|Light Protection Required
||Room Temperature: 3 day(s)
Refrigerated: 14 day(s)
Frozen (-20 °C): 30 day(s)
If this test contains multiple compounds, the reported stability reflects that which is least stable. Stability may vary among compounds included in the test and may be dependent upon matrix, pH, collection tube, and storage temperature. Negative results should be interpreted with caution. For more information on stability of a specific compound please contact the laboratory.
NOTE: If the test contains multiple compounds samples received at room temperature will not be rejected.
||Received Room Temperature. Polymer gel separation tube (SST or PST).
|Day(s) Test Set-up / TAT
||[LC-MS/MS] Tuesday / 5 days
|Suggested CPT Code
|Test Summary Sheet
*Rejection criteria pertain to clinical specimen submissions only.
**Stated minimum volume allows for a single analysis. Repeat analysis will not be performed.